Compared with the single-drug group, combined administration was more effective and led to increased sensitivity of androgen-resistant prostate cancer cells to androgen receptor-induced apoptosis (122), suggesting the potential of quercetin and curcumin administration for prevention and treatment of prostate cancer. Here, AR is linked to prostate carcinoma.